Finally, an integrated transcriptomic analysis from multiple datasets of human cancers identified TREM2-expressing TAMs in lung, colon, liver, breast, stomach, pancreas, ovaries, skin, kidney, as well as head and neck cancers [73,74,76,77]. Here, TREM2 is linked to cancer.